Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Sommer & Soliman On BINJE’s Power Players List

Powerful Praise Those who are being honored share one characteristic: They are quick to credit their colleagues. Business in New Jersey Everyday (BINJE) honored CEOs and executive directors, managing partners and principals - those who are in charge in every sector in...

New CUPR Report: Modern Rate Design in the Northeast

Modern Rate Design in the Northeast: Unlocking Efficiency, Affordability, and Electrification Read the full report Executive Summary The Northeast and Mid-Atlantic regions face some of the highest energy costs and energy burdens in the country. Regionally, energy...

Alums Contribute to DEP’s Brownfield Success StoryMap

NJDEP Brownfield Success Stories Office of Brownfield & Community Revitalization, Contaminated Site Remediation & Redevelopment Doug Leung, Josephine Michener, Emily Perez, Samantha Findeisen, Rachel Stopper, Ronald Wienckoski Bloustein School Alums Josephine...

Heldrich Center: New Multi-State Teacher Workforce Report

The Heldrich Center for Workforce Development has announced the release of a new Multi-State Teacher Workforce Report, designed to provide a comprehensive, data-driven view of the educator pipeline from preparation and certification to placement, retention, and...

Jeremy Zorek (PPP ’25) Bids MetroCard Farewell (NYT)

A Farewell Ride With the MetroCard, on Every Transit Line That Uses It In a recent New York Times feature, Rutgers Bloustein alum Jeremy Zorek (Planning and Public Policy '25) is highlighted as part of a group of transit enthusiasts undertaking a unique, all-day...